References
Appelbaum FR, Dahlberg S, Thomas ED, Buckner CD, Cheever MA, Clift RA, Crowley J, Deeg HJ, Fefer A, Greenberg PD, Kadin M, Smith W, Stewart P, Sullivan K, Storb R, Weiden P (1984) Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia. Ann Intern Med 101: 581–588
Büchner T, Urbanitz D, Hiddemann W, Rühl H, Ludwig WD, Fischer J, Aul HC, Vaupel HA, Kuse R, Zeile G, Nowrousian MA, König HJ, Walter M, Wendt FC, Sodomann H, Hossfeld DK, von Paleske A, Löffler H, Gassmann W, Hellriegel KP, Fülle HH, Luncksen C, Emmerich B, Pralle H, Pees HW, Pfreundschuh M, Bartels H, Köppen KM, Schwerdtfeger R, Donhuijsen-Ant R, Mainzer K, Bonfert B, Köppler H, Zurborn KH, Ranft K, Thiel E, Heinecke A (1985) Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group. J Clin Oncol 3: 1583–1589
Capizzi RL, Powell BL, Cooper MR, Stuart JJ, Muss HB, Richards F, Jackson DV, White DR, Spurr CL, Zekan PJ, Cruz JM, Craig JB (1985) Sequential high-dose ara-c and asparaginase in the therapy of previously treated and untreated patients with acute leukemia. Semin Oncol 12 (Suppl 3): 105–113
Champlin R, Gale RP (1987) Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies. Semin Hematol 24: 55–67
Champlin R, Ho W, Winston D, Decker R, Greenberg P, Burnison M, Holly FE, Gale RP (1987) Treatment of adults with acute myelogenous leukemia: prospective evaluation of high-dose cytarabine in consolidation chemotherapy and with bone marrow transplantation. Semin Oncol 14 (Suppl 1): 1–6
Dubovsky D, Kernoff L, Jacobs P (1978) Rapid remission induction in adult non-lymphoblastic. Eur J Cancer 14: 1179–1183
Gale RP, Champlin RE (1986) Bone marrow transplantation in acute leukaemia. Clin Haematol 15: 851–872
Gale RP, Foon KA, Cline MJ, Zighelboim J (1981) Intensive chemotherapy for acute myelogenous leukemia. Ann Intern Med 94: 753–757
Herzig RH, Lazarus HM, Wolff SN, Phillips GL, Herzig GP (1985) High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia. J Clin Oncol 3: 992–997
Hiddemann W, Kreutzmann H, Straif K, Ludwig WD, Mertelsmann R, Donhuijsen-Ant R, Lengfelder E, Arlin Z, Büchner T (1987) High-dose cytonsine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia. Blood 69: 744–749
Keating MJ, Smith TL, McCredie KB, Bodey GP, Hersh EM, Gutterman JU, Gehan E, Freireich EJ (1981) A four-year experience with anthracycline, cytosine-arabinoside, vincristine and prednisone combination chemotherapy in 325 adults with acute leukemia. Cancer 47: 2779–2788
Kurrle E, Ehninger G, Freund M, Heil G, Hoelzer D, Link H, Mitrou PS (1986) Age adapted induction and intensified consolidation therapy in acute myelogenous leukemia. Onkologie 9: 141–143
Linch DC, Burnett AK (1986) Clinical studies of ABMT in acute myeloid leukaemia. Clin Haematol 15: 167–186
Link H, Kurrle E, Frauer HM, Heil G, Heimpel H, Waller HD, Ostendorf P, Wilms K, Hoelzer D (1986) TAD-induction therapy for 175 adults with acute myeloid leukemia followed by consolidation and maintenance therapy. Onkologie 9: 135–138
Rees JK, Gray RG, Swirsky D, Hayhoe FG (1986) Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial. Lancet II: 1236–1241
Willemze R, Peters WG, van Hennik MB, Fibbe WE, Kootte AMM, van Berkel M, Lie R, Rodenburg CJ, Veltkamp JJ (1985) Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma. Scand J Haematol 34: 83–87
Wolff SN, Herzig RH, Phillips GL, Lazarus HM, Greer JP, Stein RS, Ray WA, Herzig GP (1987) High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update. Semin Oncol 14 (Suppl 1): 12–17
Wolff SN, Marion J, Stein RS (1985) High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: A pilot study. Blood 65: 1407–1411
Yates J, Glidewell O, Wiernik P, Cooper MR, Steinberg D, Dosik H, Levy R, Hoagland C, Henry P, Gottlieb A, Cornell C, Berenberg J, Hutchinson JL, Raich P, Nissen N, Ellison RR, Frelick R, James GW, Falkson G, Silver RT, Haurani F, Green M, Henderson E, Leone L, Holland JF (1982) Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study. Blood 60: 454–462
Yeager AM, Kaizer H, Santos GW, Saral R, Colvin OM, Stuart RK, Braine HG, Burke PJ, Ambinder RF, Burns WH, Fuller DJ, Davis JM, Karp JE, May WS, Rowley SD, Sensenbrenner LL, Vogelsang GB, Wingard JR (1986) Autologous bone marrow trnsplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med 315: 141–147
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kurrle, E., Ehninger, G., Freund, M. et al. A multicentre study on intensive induction and consolidation therapy in acute myelogenous leukaemia. Blut 56, 233–236 (1988). https://doi.org/10.1007/BF00320111
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00320111